These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28571021)

  • 41. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug use and abuse in sport.
    Verroken M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):1-23. PubMed ID: 10932807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic Use Exemptions.
    Gerrard D; Pipe A
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.
    Fitch KD
    Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico.
    Mercado Soberanes K; Camacho Frías E; Rodríguez Balandrán L; Rodríguez Fermán ME; Mendoza Méndez N; Velasco-Bejarano B
    Adicciones; 2019 Jul; 31(3):201-211. PubMed ID: 30059594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antidoping control in Brazil: history, current situation, and prospects for the 2014 World Cup and the 2016 Olympic Games.
    Santos MA; Silva AS; Ribeiro SL; Santos AM
    Subst Use Misuse; 2014 Jul; 49(9):1152-5. PubMed ID: 24832912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New provisions for prevention and fight against doping].
    Boulu RG
    Ann Pharm Fr; 2002 Sep; 60(5):291-5. PubMed ID: 12378136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New and old challenges of sports drug testing.
    Botrè F
    J Mass Spectrom; 2008 Jul; 43(7):903-7. PubMed ID: 18570180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-dope testing in sport: the history and the science.
    Bowers LD
    FASEB J; 2012 Oct; 26(10):3933-6. PubMed ID: 23028114
    [No Abstract]   [Full Text] [Related]  

  • 52. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Doping and sports].
    Lippi G; Guidi G
    Minerva Med; 1999 Sep; 90(9):345-57. PubMed ID: 10719440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of doping in sports: doping control in Norway, 1977-1995.
    Bahr R; Tjørnhom M
    Clin J Sport Med; 1998 Jan; 8(1):32-7. PubMed ID: 9448955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The world anti-doping program and the primary care physician.
    Hilderbrand RL
    Pediatr Clin North Am; 2007 Aug; 54(4):701-11, x-xi. PubMed ID: 17723872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidoping program: an important factor in the promotion and protection of the integrity of sport and athlete's health.
    Mazzeo F; Monda V; Santamaria S; Nigro E; Valenzano A; Villano I; Cibelli G; Messina A; Messina G
    J Sports Med Phys Fitness; 2018; 58(7-8):1135-1145. PubMed ID: 28738670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current situation and measures to promote anti-doping activities in Japan].
    Asakawa S
    Yakugaku Zasshi; 2011; 131(12):1755-6. PubMed ID: 22129872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sport, Society, and Anti-Doping Policy: An Ethical Overview.
    Bloodworth AJ; McNamee M
    Med Sport Sci; 2017; 62():177-185. PubMed ID: 28571026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.